Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Chronic Low-back Pain
NCT03181802Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Nov 2003
- Primary completion
- May 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in chronic low back pain (CLBP), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Nov 2003; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT03181802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03181802.